OPKO Health, Inc. Goodwill, Foreign Currency Translation Gain (Loss)
OPKO Health, Inc. (OPK) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$2.77 million for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-28
- OPKO Health, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$753.00K, a 110.02% decline year-over-year.
- OPKO Health, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$2.02M, a 154.84% decline year-over-year.
- OPKO Health, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $257.00K.
- OPKO Health, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$153.00K, a 104.04% decline year-over-year.
- OPKO Health, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $11.30M.
- OPKO Health, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$5.69M, a 320.46% decline from fiscal 2023.
- OPKO Health, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $2.58M.
- OPKO Health, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$5.18M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$753.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | -$2.77M 10-Q/A · filed 2026-08-28 | -$2.52M derived: sum of 3 quarters · filed 2026-08-28 | -$2.67M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2026-03-31 | -$2.02M 10-Q/A · filed 2026-08-28 | -$1.76M derived: sum of 2 quarters · filed 2026-08-28 | -$1.92M derived: sum of 3 quarters · filed 2026-08-28 | $5.60M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-12-31 | $257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $104.00K derived: sum of 2 quarters · filed 2026-02-26 | $7.62M derived: sum of 3 quarters · filed 2026-02-26 | $11.30M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $7.36M derived: sum of 2 quarters · filed 2025-10-29 | $11.04M 10-Q · filed 2025-10-29 | $4.43M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | $7.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $11.20M 10-Q · filed 2025-07-31 | $4.58M derived: sum of 3 quarters · filed 2026-02-26 | $8.37M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | $3.69M 10-Q · filed 2025-05-01 | -$2.93M derived: sum of 2 quarters · filed 2026-02-26 | $855.00K derived: sum of 3 quarters · filed 2026-02-26 | $346.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | -$6.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.83M derived: sum of 2 quarters · filed 2026-02-26 | -$3.34M derived: sum of 3 quarters · filed 2026-02-26 | -$5.69M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.28M derived: sum of 2 quarters · filed 2024-11-07 | $926.00K 10-Q · filed 2024-11-07 | $4.73M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2024-06-30 | -$509.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$2.86M 10-Q · filed 2024-08-07 | $943.00K derived: sum of 3 quarters · filed 2025-03-03 | -$1.98M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2024-03-31 | -$2.35M 10-Q · filed 2024-05-07 | $1.45M derived: sum of 2 quarters · filed 2025-03-03 | -$1.47M derived: sum of 3 quarters · filed 2025-03-03 | -$1.47M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $885.00K derived: sum of 2 quarters · filed 2025-03-03 | $879.00K derived: sum of 3 quarters · filed 2025-03-03 | $2.58M 10-K · filed 2025-03-03 | $2.58M 10-K · filed 2024-03-01 |
| 2023-09-30 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$2.92M derived: sum of 2 quarters · filed 2023-11-06 | -$1.22M 10-Q · filed 2023-11-06 | $6.56M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2023-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.70M 10-Q · filed 2023-08-03 | $9.48M derived: sum of 3 quarters · filed 2024-03-01 | $4.06M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2023-03-31 | $1.70M 10-Q · filed 2023-05-03 | $9.49M derived: sum of 2 quarters · filed 2024-03-01 | $4.06M derived: sum of 3 quarters · filed 2024-03-01 | $149.85M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-12-31 | $7.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $2.36M derived: sum of 2 quarters · filed 2024-03-01 | $148.15M derived: sum of 3 quarters · filed 2024-03-01 | -$5.18M 10-K · filed 2024-03-01 | |
| 2022-09-30 | -$5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $140.37M derived: sum of 2 quarters · filed 2022-11-08 | -$12.97M 10-Q · filed 2022-11-08 | -$166.94M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2022-06-30 | $145.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$7.54M 10-Q · filed 2022-08-04 | -$161.52M derived: sum of 3 quarters · filed 2023-02-27 | -$164.30M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2022-03-31 | -$153.33M 10-Q · filed 2022-05-09 | -$307.31M derived: sum of 2 quarters · filed 2023-02-27 | -$310.09M derived: sum of 3 quarters · filed 2023-02-27 | -$308.89M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-12-31 | -$153.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$156.76M derived: sum of 2 quarters · filed 2023-02-27 | -$155.56M derived: sum of 3 quarters · filed 2023-02-27 | -$160.00M 10-K · filed 2023-02-27 | |
| 2021-09-30 | -$2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$1.59M derived: sum of 2 quarters · filed 2021-10-28 | -$6.03M 10-Q · filed 2021-10-28 | -$1.22M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2021-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$3.24M 10-Q · filed 2021-07-29 | $1.56M derived: sum of 3 quarters · filed 2022-03-01 | $5.76M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2021-03-31 | -$4.44M 10-Q · filed 2021-04-28 | $367.00K derived: sum of 2 quarters · filed 2022-03-01 | $4.56M derived: sum of 3 quarters · filed 2022-03-01 | $6.58M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-12-31 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $9.00M derived: sum of 2 quarters · filed 2022-03-01 | $11.02M derived: sum of 3 quarters · filed 2022-03-01 | $8.66M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $6.21M derived: sum of 2 quarters · filed 2020-10-29 | $3.85M 10-Q · filed 2020-10-29 | $6.22M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2020-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$341.00K 10-Q · filed 2020-07-31 | $2.03M derived: sum of 3 quarters · filed 2021-02-18 | -$2.02M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2020-03-31 | -$2.36M 10-Q · filed 2020-05-06 | $9.00K derived: sum of 2 quarters · filed 2021-02-18 | -$4.04M derived: sum of 3 quarters · filed 2021-02-18 | -$2.71M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$1.68M derived: sum of 2 quarters · filed 2021-02-18 | -$357.00K derived: sum of 3 quarters · filed 2021-02-18 | -$2.03M 10-K · filed 2021-02-18 | |
| 2019-09-30 | -$4.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$2.72M derived: sum of 2 quarters · filed 2019-11-05 | -$4.39M 10-Q · filed 2019-11-05 | -$6.13M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2019-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$351.00K 10-Q · filed 2019-08-07 | -$2.09M derived: sum of 3 quarters · filed 2020-03-02 | -$2.69M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2019-03-31 | -$1.67M 10-Q · filed 2019-05-08 | -$3.41M derived: sum of 2 quarters · filed 2020-03-02 | -$4.01M derived: sum of 3 quarters · filed 2020-03-02 | -$9.67M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$2.34M derived: sum of 2 quarters · filed 2020-03-02 | -$8.00M derived: sum of 3 quarters · filed 2020-03-02 | -$5.21M 10-K · filed 2020-03-02 | |
| 2018-09-30 | -$605.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$6.26M derived: sum of 2 quarters · filed 2018-11-09 | -$3.47M 10-Q · filed 2018-11-09 | -$1.94M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2018-06-30 | -$5.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$2.87M 10-Q · filed 2018-08-07 | -$1.34M derived: sum of 3 quarters · filed 2019-03-01 | $2.16M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2018-03-31 | $2.79M 10-Q · filed 2018-05-08 | $4.32M derived: sum of 2 quarters · filed 2019-03-01 | $7.82M derived: sum of 3 quarters · filed 2019-03-01 | $13.90M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $5.02M derived: sum of 2 quarters · filed 2019-03-01 | $11.11M derived: sum of 3 quarters · filed 2019-03-01 | $12.50M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $9.58M derived: sum of 2 quarters · filed 2017-11-08 | $10.97M 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | $6.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $7.47M 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | $1.39M 10-Q · filed 2017-05-10 | ||||
| 2016-09-30 | $880.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$1.04M derived: sum of 2 quarters · filed 2016-11-07 | $2.89M 10-Q · filed 2016-11-07 | ||
| 2016-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $2.01M 10-Q · filed 2016-08-08 | |||
| 2016-03-31 | $3.93M 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |